Search & Filter

This year's annual GM Conference, The Ageing Patient: Midlife and Beyond was held on 9 October 2019 at 11 Cavendish Square, London. Find out more here.

Dr Davies presents a piece on iron deficiency and anaemia in patients and why it is important from The GM Conference 2016.

Dr Mike Stone present a piece on osteoporosis and prevention of fractures from The GM Conference 2015.

Dr Sanjay Surman presents a piece on Falls and Syncope from The Gm Conference 2015.

Meet the GM 2022 speakers. Find out who will be leading the speaker sessions at this year's annual London conference, Health and Ageing in a post Covid NHS, and what they do.

The more regularly people report doing word puzzles such as crosswords, the better their brain function in later life, a large-scale trial has found.

Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially life-saving drugs, according to recent research.

Public Health England (PHE) has published for the first time a report on the health of the population in England.

Experiencing physical, sexual or emotional abuse as a child, or other stresses such as living in a household affected by domestic violence, substance abuse or mental illness, can lead to higher levels of health service use throughout adulthood.

People are living longer, with life expectancy now at 79.5 years for me and 83.1 years for women €“ but much of that extra time is spent in poor health, new research by Public Health England has revealed.

Researchers have called for better screening to identify monogenic diabetes, following the development of a test which helped identify more cases of the condition.

Ferric carboxymaltose (Ferinject) may have a positive impact on morbidity and mortality in patients with systolic heart failure as three trials have been initiated to evaluate its efficacy on morbidity and mortality outcomes in patients with systolic heart failure and iron deficiency.

A technique borrowed from neuroscience to see through brain tissue is helping scientists to see the fine structure of the heart.

The National Institute for Health and Care Excellence (NICE) recommends cabozantinib as an option for people with advanced renal cell carcinoma.

Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods, according to research published in the British Journal of Cancer.